Selected adipokines and metabolic profiles in normal-weight women with abdominal obesity

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 9, 2012, Pages 406-412

  Miazgowski, Tomasz ^a   Major Gołuch, Agnieszka ^a   Safranow, Krzysztof ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Abdominal obesity; Adiponectin; Adiposity; Visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HIP FAT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID STORAGE; MAJOR CLINICAL STUDY; NORMAL WEIGHT; PREMENOPAUSE; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84868658569     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1375     Document Type: Article

References (28)

1. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/IDF-Meta-def-final. pdf. Accessed May 15, 2011.
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001; 285: 2486-2497.
3. Grundy SM, Brewer HB Jr, Cleeman JI, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004; 109: 433-438. (Pubitemid 38133916)
4. Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem. 2011; 44: 281-287.
5. Kaser S, Tatarczyk T, Stadlmayr A, et al. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Incest. 2008; 38: 827-834.
6. Brooks NL, Moore KS, Clark RD, et al. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? Diabetes Obes Metab. 2007; 9: 246-258. (Pubitemid 46502042)
7. Cook JR, Semple RK. Hypoadiponectinemia - cause or consequence of human "insulin resistance"? J Clin Endocrinol Metab. 2010; 95: 1544-1554.
8. Esteghamati A, Alamdari A, Zandieh A, et al. Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity. Diabetes Res Clin Pract. 2011; 91: 154-158.
9. Nakamura Y, Sekikawa A, Kadowaki T, et al. Visceral and subcutaneous adiposity and adiponectin in middle-aged Japanese men: the ERA JUMP study. Obesity (Silver Spring). 2009; 17: 1269-1273.
10. Krzyżanowska K, Krugluger W, Mittermayer F, et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond). 2006; 110: 605-609. (Pubitemid 43736123)
11. Zhong M, Tan HW, Gong HP, et al. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin Endocrinol (Oxf). 2008; 69: 878-884.
12. Kim JH, Kim SH, Im JA, Lee DC. The relationship between visfatin and metabolic syndrome in postmenopausal women. Maturitas. 2010; 67:67-71.
13. Haider DG, Schindler K, Schaller G, et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006; 91: 1578-1581.
14. Lee K, Lee S, Kim YJ, Kim YJ. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition. 2008; 24: 625-631.
15. Rissanen P, Hämäläinen P, Vanninen E, et al. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women. Int J Obes Relat Metab Disord. 1997; 21: 367-371. (Pubitemid 27190188)
16. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes. 1999; 48: 2210-2214. (Pubitemid 29521852)
17. Conus F, Allison DB, Rabasa-Lhoret R, et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab. 2004; 89: 5013-5020. (Pubitemid 39391442)
18. Yabanci N, Gocgeldi E, Simsek I, et al. Prevalence of obesity, abdominal obesity and the associated factors among a group of Turkish adults. Pak J Med Sci. 2010; 26: 21-25.
19. Koukoulis GN, Sakka C, Katsaros F, et al. High rates of obesity prevalence in adults living in central Greece: data from the ARGOS study. Hormones (Athens). 2010; 9: 253-262.
20. Marques-Vidal P, Bochud M, Mooser V, et al. Prevalence of obesity and abdominal obesity in the Lausanne population. BMC Public Health. 2008; 8: 330.
21. Kwon S. Association between abdominal obesity and cardiovascular risk factors in normal-weight Korean women. Health Care Women Int. 2009; 30: 447-452.
22. Janghorbani M, Amini M, Willett WC, et al. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity (Silver Spring). 2007; 15: 2797-2808.
23. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007; 28: 850-856. (Pubitemid 47343598)
24. Czernichow S, Kengne AP, Huxley RR, et al.; ADVANCE Collaborative Group. Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type 2 diabetes: a prospective cohort study from ADVANCE. Eur J Cardiovasc Prev Rehabil. 2011; 18: 312-319.
25. Okura T, Nakata Y, Yamabuki K, Tanaka K. Regional body composition changes exhibit opposing effects on coronary heart disease risk factors. Arterioscler Thromb Vasc Biol. 2004; 24: 923-929. (Pubitemid 38620873)
26. Parker ED, Pereira MA, Stevens J, Folsom AR. Association of hip circumference with incident diabetes and coronary heart disease: the Atherosclerosis Risk in Communities study. Am J Epidemiol. 2009; 169: 837-847.
27. Badaruddoza NK, Barna B. Inter-relationship of waist-to-hip ratio (WHR), body mass index (BMI) and subcutaneous fat with blood pressure among university-going Punjabi Sikh and Hindu females. International Journal of Medicine and Medical Science. 2010; 2: 5-11.
28. Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord. 2001; 25: 652-661. (Pubitemid 32417634)